Celularity Inc. Files 8-K on Security Holder Vote Matters

Ticker: CELUW · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1752828

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, filing-update

Related Tickers: CELU

TL;DR

Celularity Inc. (CELU) is holding a shareholder vote on Dec 19, 2025 - expect news soon.

AI Summary

Celularity Inc. filed an 8-K on December 19, 2025, reporting on the submission of matters to a vote of security holders. The company, formerly GX Acquisition Corp., is incorporated in Delaware and operates in the pharmaceutical preparations sector. The filing details information related to its common stock and warrants.

Why It Matters

This filing indicates that Celularity Inc. is engaging its security holders in important corporate decisions, which could impact the company's future direction and shareholder value.

Risk Assessment

Risk Level: medium — Filings related to shareholder votes can sometimes precede significant corporate actions or changes that may affect stock price.

Key Numbers

Key Players & Entities

FAQ

What specific matters are being submitted to a vote of Celularity Inc.'s security holders?

The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals in the provided excerpt.

When was Celularity Inc. formerly known as GX Acquisition Corp.?

The date of the name change from GX Acquisition Corp. to Celularity Inc. was September 12, 2018.

What is Celularity Inc.'s primary business sector?

Celularity Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.

Where is Celularity Inc. headquartered?

Celularity Inc.'s principal business address is 170 Park Ave, Florham Park, New Jersey, 07932.

What is the SEC file number for Celularity Inc.?

The SEC file number for Celularity Inc. is 001-38914.

Filing Stats: 663 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-12-19 16:15:41

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC. Date: December 19, 2025 By: /s/ Robert J. Hariri Robert J. Hariri, M.D., Ph.D. Chairman and CEO

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing